Ptc Therapeutics Stock Forecast

Sell candidate since Jul 30, 2026 Loss -1.18%

The PTC Therapeutics stock price gained 1.80% on the last trading day (Monday, 10th Aug 2026), rising from $73.31 to $74.63. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 3.14% from a day low at $72.48 to a day high of $74.75. The price has risen in 7 of the last 10 days but is still down by -1.54% for this period. Volume fell on the last day by -136 thousand shares and in total, 796 thousand shares were bought and sold for approximately $59.38 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.96% during the next 3 months and, with a 90% probability hold a price between $72.59 and $96.82 at the end of this 3-month period.

PTCT Signals & Forecast

There are mixed signals in the stock today. The PTC Therapeutics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $78.91. On a fall, the stock will find some support from the short-term average at $70.46. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Friday, July 31, 2026, and so far it has risen 9.73%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. The stock had a Golden Star Signal on Wednesday, August 13, 2025 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for PTC Therapeutics stock

PTC Therapeutics finds support from accumulated volume at $73.68 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.28 between high and low, or 3.14%. For the last week, the stock has had daily average volatility of 3.08%.

Since the PTC Therapeutics has been rising for 6 days in a row, the risk over the next couple of days has increased.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PTCT) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect PTC Therapeutics to open at $73.95, and during the day (based on 14 day Average True Range), to move between $73.07 and $76.19, which gives a possible trading interval of +/-$3.12 (+/-4.28%) up or down from last closing price. If PTC Therapeutics takes out the full calculated possible swing range there will be an estimated 4.28% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $73.68 (1.27%) than the resistance at $76.77 (2.87%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is PTC Therapeutics stock A Buy?

PTC Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.624 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $73.95 ( 0.91%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk